Theresa Tomblin, PHARMD | |
1419 Chapin Rd., Chapin, SC 29036-0759 | |
(803) 345-0679 | |
(803) 345-1817 |
Full Name | Theresa Tomblin |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 1419 Chapin Rd., Chapin, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962770388 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 010874 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Theresa Tomblin, PHARMD 1419 Chapin Rd., Chapin, SC 29036-0759 Ph: (803) 345-0679 | Theresa Tomblin, PHARMD 1419 Chapin Rd., Chapin, SC 29036-0759 Ph: (803) 345-0679 |
News Archive
Cancer researchers dream of the day they can force tumor cells to morph back to the normal cells they once were. Now, researchers on Mayo Clinic's Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Omnicell, Inc., a leading provider of system solutions to acute healthcare facilities, today announced that South Jersey Healthcare (SJH) Regional Medical Center has implemented Omnicell 14.0 with Anywhere RN(TM), a software solution used in conjunction with Omnicell's automated medication dispensing cabinets to ensure safe, efficient and accessible medication management throughout the hospital. South Jersey Healthcare was one of the first hospitals to implement Omnicell 14.0, which is now available to all Omnicell customers.
Intermedix Corporation, a leading provider of revenue cycle management and software solutions to the emergency healthcare industry, announced today that Thomas H. Lee Partners, L.P. has signed a definitive merger agreement to acquire the Company from Parthenon Capital Partners and its minority shareholders.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX in the EU, announced today that it has injected the first patient in its placebo-controlled Phase 2 clinical trial of CCH for the treatment of lipoma.
› Verified 3 days ago
Robert Bennett Lominack, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1419 Chapin Rd., Chapin, SC 29036 Phone: 803-345-0029 Fax: 803-345-1817 | |
Tammy Hendrix, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1401 Chapin Rd, Chapin, SC 29036 Phone: 803-345-0759 | |
Renee Haynes Holstein, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 105 Snapdragon Ct, Chapin, SC 29036 Phone: 803-422-6956 | |
Terri W Frick, BS RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1401 Chapin Rd, Chapin, SC 29036 Phone: 803-345-1175 Fax: 803-932-7706 | |
Mr. Justin Palmer Carter, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 105 Snapdragon Ct Ste A, Chapin, SC 29036 Phone: 803-345-9999 Fax: 803-888-2089 | |
Dr. Kelly Jane Clark, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 328 Quail Walk Trl, Chapin, SC 29036 Phone: 803-935-9702 Fax: 803-935-4564 | |
Dr. Candice Elaine Landin, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1401 Chapin Rd, Chapin, SC 29036 Phone: 803-345-0759 |